← Journal

Metabolic Health

Blood Work for Testosterone Therapy (TRT): What to Monitor and Why

If you're on testosterone — or thinking about it — the honest, unglamorous part is the monitoring that keeps it safe. This is a plain-language guide to the blood work that matters on TRT, written for the male expats and medical travellers in Pattaya, many of whom arrived already on testosterone with no follow-up at all.

12 Jun 2026 · 8 min read

If you're on testosterone, or you're thinking about starting, this is the part nobody put on the box: the unglamorous follow-up blood work that keeps the treatment safe. Testosterone replacement therapy (TRT) can genuinely help men with a real, confirmed deficiency — but it isn't a wellness booster, and it isn't something to run unmonitored. The honest job of this article is to explain what should be checked, how often, and above all why — because the most serious risk of TRT is silent, shows up only on a blood test, and is easy to manage if someone is actually looking for it. This is general education, not a diagnosis or a prescription; testosterone therapy is specialist-led, and it starts with confirming you need it at all.

First — is TRT even the right question?

Before any monitoring matters, the diagnosis has to be real. Testosterone therapy is for men with confirmed deficiency: two low morning testosterone readings on separate days, plus consistent symptoms — not a single below-the-line number, and not "low T" diagnosed from how you feel after a bad month 5. That distinction is the whole game. Treating a one-off number, or chasing testosterone as a general pick-me-up, is exactly what the major guidelines advise against. If you're still at the stage of working out whether your level is genuinely low, start with our guide to the testosterone test and what "low T" really means; this article picks up after a deficiency has been properly confirmed and treatment is being considered or is already underway.

It's worth being blunt about the limits, too. TRT is not an anti-ageing therapy, and the benefit and safety of treating age-related low testosterone in otherwise-healthy older men are not established — that use is off-label and uncertain 4. Testosterone also suppresses the body's own sperm production and can affect fertility, which matters a great deal if you might still want children 5. None of that means TRT is wrong for the men who truly need it — it means the decision, and the monitoring, belong with a doctor.

What's checked before you start?

Good practice front-loads the safety work. Before the first dose, a doctor establishes a baseline so that later changes are meaningful 1:

  • Haemoglobin and haematocrit — your baseline blood "thickness," because testosterone will push these up (more on this below). If your baseline haematocrit is already over 50%, that's a reason to pause and reconsider before starting 1.
  • PSA (prostate-specific antigen) — in men over 40, to help exclude prostate cancer before beginning, since testosterone shouldn't be started over an unexamined prostate concern 1.
  • Plus the confirmed-low testosterone readings that justified treatment in the first place, and usually a lipid (cholesterol) panel as part of the overall picture.

What's monitored once you're on it?

Once therapy starts, the same markers are rechecked on a schedule to confirm the dose is right and nothing is drifting into dangerous territory. The typical monitored panel is total testosterone (sometimes free testosterone too), haemoglobin/haematocrit, PSA, and lipids — with oestradiol added only if symptoms call for it 2.

How often? The honest answer is "it depends," but the general rhythm is to recheck your testosterone level, haematocrit and clinical response at follow-up — with haematocrit revisited roughly every 6–12 months, and sooner if a prior value was creeping up 2. PSA on therapy is tracked using a shared-decision-making approach, in line with prostate-cancer early-detection guidance, rather than as an automatic alarm on any single change 1.

Why is haematocrit the number that matters most?

This is the heart of the article. Testosterone stimulates the bone marrow to make more red blood cells. That sounds harmless — but pushed too far it tips into erythrocytosis (also called polycythaemia): too many red cells, and thicker blood 3. Thick blood flows less easily and clots more readily, and that's not a theoretical worry. Secondary polycythaemia driven by TRT is associated with an increased rate of major adverse cardiovascular events (MACE) — heart attacks and strokes — and venous thromboembolism (VTE), the blood clots that form in the legs and can travel to the lungs, with the risk highest in the first year of treatment 3.

That's why the haematocrit thresholds are taken seriously 1:

  • A baseline haematocrit over 50% is a reason to withhold starting TRT until it's understood.
  • On therapy, a haematocrit of 54% or above warrants action — typically reducing the dose, a temporary stop, switching to a different testosterone formulation, or therapeutic phlebotomy (drawing off a unit of blood, much like a blood donation, to bring the level down).

The reassuring part is that this is findable and fixable — but only if someone is checking. A man on testosterone who never has his haematocrit measured can develop thick blood with no symptoms at all, right up until something goes wrong. The blood test is the early-warning system.

What we see at the clinic

Pattaya is, frankly, a city where a fair number of men arrive already on testosterone — bought online, picked up abroad, or started elsewhere — with no monitoring behind it at all. They feel fine, the box keeps getting refilled, and nobody has looked at their haematocrit, their PSA, or whether the dose even makes sense. That gap is exactly what this article is about. We do not promote "boost your T," we don't sell testosterone as a lifestyle upgrade, and we won't start it on a single number or a vibe. What we do is take an honest baseline, run the right follow-up panel, and put the results in front of a doctor — so that a man who has chosen TRT, or who needs it, isn't quietly running an unmonitored cardiovascular risk. If you're already on testosterone and haven't had blood work in a while, that catch-up is genuinely worth doing, and the practical side of getting bloods done is easy.

Common questions

I feel great on my testosterone — do I really need blood tests? Yes, and feeling great is precisely why it matters. The most serious risk — thick blood from rising red-cell counts — usually causes no symptoms until something goes wrong, so the blood test is the only early warning you get 3. Monitoring is how good TRT stays safe TRT.

What exactly is "thick blood," and is it really dangerous? Testosterone raises red-cell production, and too much tips into erythrocytosis — more cells, thicker blood that clots more easily 3. On TRT, that secondary polycythaemia is linked to more heart attacks, strokes and clots in the lungs and legs, especially in the first year 3 — which is why a haematocrit of 54% or above triggers action 1.

Should my oestrogen (oestradiol) be checked and "managed"? Not routinely. Oestradiol is measured only if you develop breast tenderness or gynaecomastia — it isn't a number to chase on every panel, and routine "estrogen control" isn't part of standard monitoring 1.

How often will I actually need bloods on TRT? Your testosterone, haematocrit and response are rechecked at follow-up, with haematocrit roughly every 6–12 months and sooner if it's been climbing 2. PSA is followed through shared decision-making rather than on a fixed alarm 1. Exact ranges and intervals differ by lab and by person.

Can TRT affect my fertility? Yes — testosterone suppresses the body's own sperm production and can reduce fertility, sometimes significantly 5. If having children is a possibility for you, raise it before starting, because it changes the conversation.

Key takeaway

Testosterone therapy, for the man who genuinely needs it, is a legitimate treatment — but it is specialist-led, it begins with a confirmed diagnosis rather than a single number, and it lives or dies on the monitoring 45. The non-negotiable check is haematocrit: because testosterone thickens the blood, and thick blood means clots and cardiovascular risk, a baseline is taken before you start and the level is rechecked on a schedule, with action at 54% or above 13. If you're already on testosterone and haven't had that blood work, the honest, safe move is to get it done — not to boost the dose, but to make sure the quiet risks aren't building unwatched 2.

Sources

  1. AUA — Testosterone Deficiency Guideline (full PDF; baseline Hb/Hct, PSA over 40, haematocrit thresholds, PSA shared decision-making, oestradiol only if symptomatic)
  2. AUA — Follow-up Laboratory Testing (Table 7 PDF; what to recheck and how often)
  3. PMC — Secondary polycythaemia on TRT increases MACE/VTE (editorial comment; risk highest in the first year)
  4. Endocrine Society — Testosterone Therapy for Hypogonadism (clinical practice guideline; confirmed deficiency, age-related uncertainty)
  5. StatPearls (NCBI Bookshelf) — Male Hypogonadism (diagnosis, two low morning levels, fertility effects)

For general information and education only — not medical advice. Read our disclaimer.